BAC vs COLL · P/E 13, rev $113.10B vs P/E 17, rev $181.9M
Bank of America Corp (BAC) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BAC and COLL stock pages for the full models.
Not investment advice.